Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.28 USD | -6.23% | -12.33% | -7.25% |
Mar. 27 | Wells Fargo Trims Price Target on Bluebird Bio to $3 From $4, Maintains Equalweight Rating | MT |
Mar. 27 | Wedbush Adjusts bluebird bio's PT to $1.72 From $1.68, Maintains Neutral Rating | MT |
Financials (USD)
Sales 2023 * | 38.13M | Sales 2024 * | 128M | Capitalization | 247M |
---|---|---|---|---|---|
Net income 2023 * | -199M | Net income 2024 * | -233M | EV / Sales 2023 * | 0.93 x |
Net cash position 2023 * | 211M | Net cash position 2024 * | 152M | EV / Sales 2024 * | 0.75 x |
P/E ratio 2023 * |
-0.75
x | P/E ratio 2024 * |
-0.78
x | Employees | 323 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 99.62% |
Latest transcript on bluebird bio, Inc.
1 day | -6.23% | ||
1 week | -12.33% | ||
Current month | -7.91% | ||
1 month | -23.81% | ||
3 months | -9.22% | ||
6 months | -57.62% | ||
Current year | -7.25% |
Managers | Title | Age | Since |
---|---|---|---|
Andrew Obenshain
CEO | Chief Executive Officer | 51 | 15-12-31 |
Director of Finance/CFO | 51 | 22-11-06 | |
Melissa Bonner
CTO | Chief Tech/Sci/R&D Officer | - | 21-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Vachon
CHM | Chairman | 65 | 14-07-15 |
Nick Leschly
BRD | Director/Board Member | 51 | 10-02-28 |
Richard Paulson
BRD | Director/Board Member | 56 | 23-04-02 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.47% | 17 M€ | -0.46% | ||
0.11% | 227 M€ | +5.31% | - | |
0.10% | 12 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1.28 | -6.23% | 7,269,558 |
24-03-27 | 1.365 | +13.75% | 6,877,196 |
24-03-26 | 1.2 | -11.76% | 18,169,512 |
24-03-25 | 1.36 | -0.73% | 4,510,559 |
24-03-22 | 1.37 | -6.16% | 5,589,301 |
Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.25% | 247M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |